Inhibition of extracellular traps by spores of Trichoderma stromaticum on neutrophils obtained from human peripheral

Lucilla Silva Oliveira-Mendonça1, Danielle de Sousa Lopes1, Adriana Bozzi2

  • 1Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Bahia, Brazil.

Molecular Immunology
|November 19, 2021
PubMed

Insights

Trichoderma stromaticum spores may inhibit neutrophil extracellular traps (NETs) and modulate human immune responses. Further research is crucial given its agricultural use and potential therapeutic applications.

Area of Science:

  • Immunology
  • Mycology
  • Biotechnology

Background:

  • The biocontrol agent Trichoderma is widely used in agriculture, but its effects on the human immune system are largely unknown.
  • Previous studies showed Trichoderma asperelloides and Trichoderma stromaticum spores impact mouse immune responses, including reduced neutrophil counts and altered cytokine levels.

Purpose of the Study:

  • To investigate the effects of Trichoderma stromaticum spores on human peripheral neutrophils.
  • To determine if T. stromaticum influences neutrophil extracellular trap (NET) formation and related gene/microRNA expression.

Main Methods:

  • Human peripheral neutrophils were co-cultured with T. stromaticum spores.
  • Neutrophil extracellular trap (NET) release was induced using phorbol 12-myristate 13-acetate.
  • Gene and microRNA expression levels were analyzed using quantitative PCR and other molecular techniques.

Main Results:

  • T. stromaticum spores significantly reduced NET release from human neutrophils.
  • The interaction decreased the expression of key NET-related genes (ELANE, MPO, PADI4) and specific microRNAs (miR-221, miR-222, miR-223, miR-27a).
  • Spore exposure altered the expression of genes involved in neutrophil inflammatory signaling pathways (SOCS3, TLR4, CSNK2A1, GSDMD, NFFKBIA).

Conclusions:

  • Trichoderma stromaticum exhibits potential as a NET inhibitor and immunomodulatory agent.
  • Findings highlight the need to understand the human immune system's response to this common biocontrol fungus.
  • Further study of T. stromaticum compounds may lead to new anti-inflammatory drug development.

Related Concept Videos